NTHI - NASDAQ
Neonc Technologies Holdings, Inc.
$4.35
-4.2%Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
At a Glance
Live SnapshotNeonc Technologies Holdings, Inc. Management Team
Mr. Keithly A. Garnett
Chief Financial Officer & Director
Compensation
$179,000
Mr. Patrick Walters CPA
Chief Operating Officer
Compensation
$195,000
Dr. Thomas C. Chen M.D., Ph.D.
Founder, Chief Executive Officer, Chief Scientific Officer & Director
Compensation
$212,000
Mr. Amir Farrokh Heshmatpour
President, Executive Chairman & Secretary
Neonc Technologies Holdings, Inc. Insider Positioning
During the last 12 months, insiders have purchased $65K worth of NTHI shares, with no selling activity reported.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
10.0K
65.06K
0
0.00
+65K
+$65K
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
Heshmatpour Amir F
Director, 10 Percent Owner, Officer: President
$65K
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $65K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Insider Participation
1 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Unanimous insider buying: Zero selling combined with active buying is rare and typically very bullish. Insiders appear to see significant upside with limited downside risk.
SEC Filings
NTHI - Filing history and reports
No SEC filings available for NTHI
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.